MarginsXMarginsX
Home › Markets › Health Care › INBS

Intelligent Bio Solutions Inc. (INBS)

INBS trades on Nasdaq in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$1.50
-16.20% on the day
Market cap
$5.0M
Nano cap
Revenue · 2026
$4.2M
+38.1% on 2025
Net income · 2026
-$12.4M
-294.9% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2026-06-30, https://www.sec.gov/Archives/edgar/data/1725430/000149315226039136/0001493152-26-039136-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2026-06-30.

Profile

FieldValue
TickerINBS on Nasdaq
SectorHealth Care
IndustryMedical/Dental Instruments
CountryUnited States
IPO year2020
SEC CIK0001725430
SEC industry codeSurgical & Medical Instruments & Apparatus
Incorporated inDE

Financials · 2026

LineValue
Revenue$4.2M
Net income-$12.4M
Operating income-$12.6M
Net margin-294.9%
Operating margin-299.1%
Revenue growth+38.1%
Cash$4.0M
Total assets$11.9M
P/E (computed)Net income was not positive
P/S (computed)1.2×

Warning signs

Cash runway
6.0 months
$5.9M cash at September 30, 2026
Share count, 1 year
+250.9%
2025-11-10 to 2026-11-10 · +4456.9% over 3 years
Going-concern doubt
Yes
10-Q filed November 10, 2026
Insider net buying, 12 months
$0
Through September 30, 2026
SignFindingSource
Going concernStates substantial doubt about continuing as a going concern.
"Accordingly, these factors raise substantial doubt about the Company's ability to continue as a going concern."
10-Q 2026-11-10
Cash and burn$5.9M cash; operating cash flow -$3.0M a quarter.Report 2026-09-30
Shares outstanding3,316,803 (2026-11-10); 9,452,553 a year earlier; 8,734,381 three years earlier. 1y figure adjusted for splits (1-for-10 overall); 3y figure adjusted for splits (1-for-120 overall).Cover page 2026-11-10
Reverse splits, 3 years2; latest 1-for-10 on 2025-12-16Source 2025-12-16
Shelf and offerings, 12 months2 S-3/F-3 shelf filings; 1 424B5 takedowns, 1 at the marketLatest 2026-03-23
Exchange deficiency notices, 12 months1 (8-K item 3.01)8-K 2025-12-16
AuditorUHY LLP, Melville, New York, United StatesPCAOB Form AP 2026-08-28
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q1 2027
2026-09-30
$1.4M-$2.7M-$2.8M$5.9MNo debt tags$4.5M10-Q 2026-11-10
Q4 2026
2026-06-30
$1.1M-$3.9M-$3.2M$4.0M$0$4.2M10-K 2026-08-19
Q3 2026
2026-03-31
$1.1M-$2.9M-$4.3M$6.9MNo debt tags$3.9M10-Q 2026-05-13
Q2 2026
2025-12-31
$897K-$2.7M-$1.6M$740K$13K$3.8M10-Q 2026-02-12
Q1 2026
2025-09-30
$1.1M-$3.0M-$2.8M$1.7M$140K$3.6M10-Q 2026-11-10
Q4 2025
2025-06-30
$844K-$3.1M-$2.2M$1.0M$197K$3.5M10-K 2026-08-19
Q3 2025
2025-03-31
$902K-$2.5M-$2.8M$2.8M$356K$3.4M10-Q 2025-05-13
Q2 2025
2024-12-31
$741K-$2.2M-$2.3M$2.2M$406K$3.4M10-Q 2025-02-13

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B32026-09-23
Latest annual report10-K/A2026-10-21
Latest quarterly / interim10-Q2026-11-10
Latest current report8-K2026-11-10
Latest proxyDEF 14A2026-11-02

Source: SEC EDGAR submissions feed, 469 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week-10.7%
1 month+18.9%
3 months-41.3%
Year to date-81.5%
1 year-75.5%
From 52-week high-90.2%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Medical/Dental Instruments

TickerCompanyPriceDayMarket cap
ICUSeaStar Medical Holding Corporation$0.8535+1.80%$4.5M
BDMDBaird Medical Investment Holdings Ltd Ordinary Share$0.1065+17.68%$4.5M
WOKWORK Medical Technology Group LTD$1.23+2.50%$5.5M
SNOASonoma Pharmaceuticals Inc.$0.8802-19.25%$4.5M
NVNOenVVeno Medical Corporation$5.95-3.65%$4.1M
NMTCNeuroOne Medical Technologies Corporation$0.7450-0.01%$6.8M
TNONTenon Medical Inc.$1.33-5.32%$3.6M
CNSYCerenome Inc. Common Stock$0.7148-24.77%$7.0M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier